TKL Research

TKL Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

TKL Research is a long-established, family-owned Contract Research Organization (CRO) headquartered in Paramus, New Jersey, USA. Founded in 1998 but leveraging an 80-year legacy, the company provides comprehensive clinical trial management services with a noted specialization in dermatology. It differentiates itself through a personalized, 'not your average CRO' approach, offering end-to-end solutions from Phase I studies through later-phase trial management for its biopharma clients.

Dermatology

Technology Platform

Integrated clinical trial service model with expertise in innovative study design, streamlined operations, and a dedicated Phase I clinical unit. Leverages over 80 years of collective industry experience, particularly in dermatology.

Opportunities

Growth is driven by the expanding global dermatology therapeutics market and the biopharma industry's ongoing reliance on CROs to outsource complex, costly clinical development.
Its specialized expertise and Phase I unit position it to capture early-stage projects and build long-term client partnerships.

Risk Factors

Faces intense competition from large global and niche CROs.
Revenue is contingent on winning competitive contracts, creating client concentration and cyclical risks.
Operational failures in trial execution could damage its reputation and future business prospects.

Competitive Landscape

Operates in the highly competitive CRO market, competing against large global players (e.g., IQVIA, ICON) and other specialized dermatology CROs. Its differentiation is based on its long heritage, family-owned/operated model promising personalized service, and deep, focused expertise in dermatological clinical trials.